Overview of regulatory expectations for introducing novel therapies into clinical trials -- Preparation of clinical trial supplies of biopharmaceuticals -- Proteins as drugs: analysis, formulation and delivery -- Strategies for dealing with the immunogenicity of therapeutic proteins -- Targeted toxin hybrid proteins -- SB209763: a humanized monoclonal antibody for the prophylaxis and treatment of respiratory syncytial virus infection -- Preclinical development of antisense therapeutics -- Formulation and delivery of nucleic acids -- Safe, efficient production of retroviral vectors -- Clinical systems for the production of cells and tissues for human therapy -- Subject index
Access-restricted-item
true
Addeddate
2020-05-08 08:01:45
Associated-names
Abuchowski, A; Oxender, Dale L; Post, Leonard E., 1952-
